Microrna molecules
CA 2937159 C · Owner: Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. · Inventors: Rauhut, Reinhard; Tuschl, Thomas; Dammann, Jutta
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In Caenorhabditis elegans, lin-4 and let-7 encode 22- and 21 -nucleotide RNAs respectively, that function as key regulators of developmental timing. Because the appearance of these short RNAs is regulated during development they are also referred to as "small temporal RNAs" (stRNAs). We show that many more 21- and 22-nt expressed RNAs termed microRNAs, (miRNAs), exist in invertebrates and vertebrates and that some of these novel RNAs, similar to let-7 stRNA are also highly conserved. This suggests that sequence-specific post-transcriptional regulatory mechanisms mediated by small RNAs are more general than previously appreciated.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 27, 2002 and granted November 28, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.